Literature DB >> 21223432

Anterior temporal artery sign in CT angiography predicts reduced fatal brain edema and mortality in acute M1 middle cerebral artery occlusions.

Bijoy K Menon1, Simerpreet Bal, Jayesh Modi, Sung I I Sohn, Timothy W J Watson, Michael D Hill, Andrew M Demchuk, Mayank Goyal.   

Abstract

BACKGROUND: Mortality in acute ischemic middle cerebral artery (MCA) stroke ranges from 5% to 45%. We identify a vascular imaging sign, presence of "prominent anterior temporal artery" on computed tomography (CT) angiography (CTA) and investigate whether it predicts mortality in acute M1-MCA occlusions.
METHODS: One hundred and two patients with acute M1-MCA occlusions from 2003-to 2007 were included in the study. A prominent anterior temporal artery arising from proximal M1 MCA was identified by two readers blinded to clinical outcome. Primary clinical outcome was survival (modified Rankin Scale [mRS] 0-5) at 3 months.
RESULTS: An anterior temporal artery arising from M1 MCA was present in 20/102 (20%). Eighteen of 20 (90%) patients with this sign survived at 3 months (mRS 0-5) when compared to 66/82 (80.4%) patients without the sign (odds ratio 2.2 CI(95) .5-10.4). The sign has a sensitivity of 21% (CI(95) .13-.25) but specificity of 89% (CI(95) .64-.98) in predicting survival at 3 months. Positive predictive value was 90% with likelihood ratio of 1.9 (CI(95) .9-7.6).
CONCLUSION: Presence of prominent anterior temporal artery in M1-MCA occlusions on CTA identifies a group of patients with reduced case fatality. The mechanism is likely related to a reduced chance of malignant cerebral edema.
Copyright © 2011 by the American Society of Neuroimaging.

Entities:  

Mesh:

Year:  2011        PMID: 21223432     DOI: 10.1111/j.1552-6569.2010.00566.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  6 in total

1.  Strategies of collateral blood flow assessment in ischemic stroke: prediction of the follow-up infarct volume in conventional and dynamic CTA.

Authors:  S E Beyer; K M Thierfelder; L von Baumgarten; M Rottenkolber; F G Meinel; H Janssen; B Ertl-Wagner; M F Reiser; W H Sommer
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

2.  Predictive value of the velocity of collateral filling in patients with acute ischemic stroke.

Authors:  Sebastian E Beyer; Louisa von Baumgarten; Kolja M Thierfelder; Marietta Rottenkolber; Hendrik Janssen; Martin Dichgans; Thorsten Rc Johnson; Andreas Straube; Birgit Ertl-Wagner; Maximilian F Reiser; Wieland H Sommer
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-05       Impact factor: 6.200

Review 3.  Malignant MCA Stroke: an Update on Surgical Decompression and Future Directions.

Authors:  Carolina B Maciel; Kevin N Sheth
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

4.  Visualization of the Anterior Temporal Artery as a Predictor of Outcome in Middle Cerebral Artery Occlusion Patients Achieving Successful Recanalization After Transfer.

Authors:  Jonathan M Parish; Jeremy B Rhoten; Dale Strong; Tanushree Prasad; Andrew Hines; Joe D Bernard; Jonathan Clemente; Rahul Karamchandani; Andrew W Asimos; William R Stetler
Journal:  Cureus       Date:  2022-05-20

5.  Presence of anterior temporal artery associates with good outcome in acute atherosclerotic M1-middle cerebral artery occlusion.

Authors:  Dezhi Liu; Yongkun Li; Zhaorong Shi; Stephen M Davis; Ka Sing Wong; Thomas W Leung; Bernard Yan; Yunyun Xiong; Wen Sun; Gelin Xu; Renliang Zhang; Xinfeng Liu
Journal:  Neuroradiology       Date:  2014-09-09       Impact factor: 2.804

6.  Lysine acetyltransferase PCAF is a key regulator of arteriogenesis.

Authors:  Antonius J N M Bastiaansen; Mark M Ewing; Hetty C de Boer; Tineke C van der Pouw Kraan; Margreet R de Vries; Erna A B Peters; Sabine M J Welten; Ramon Arens; Scott M Moore; James E Faber; J Wouter Jukema; Jaap F Hamming; A Yaël Nossent; Paul H A Quax
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-20       Impact factor: 8.311

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.